Shareholder plans Rule 144 sale of 9,797 shares

A shareholder filed a Rule 144 notice to sell 9,797 common shares through UBS Financial Services on the NYSE, with an aggregate market value of $1,112,051.43.

Rhea-AI Filing Summary

A shareholder filed a Rule 144 notice to sell 9,797 common shares through UBS Financial Services on the NYSE, with an aggregate market value of $1,112,051.43. The shares were acquired on 02/04/2026 via a stock option release from the issuer. Shares outstanding were 857,360,396 at the time listed, providing context for the sale’s relative size.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the Form 144 filing for GLW indicate about planned share sales?

The filing shows a shareholder plans to sell 9,797 common shares under Rule 144. These shares have an aggregate market value of $1,112,051.43 and are expected to be sold on the NYSE through UBS Financial Services.

How many GLW shares are covered by this Rule 144 notice and what is their value?

The notice covers 9,797 common shares with an aggregate market value of $1,112,051.43. This provides a clear view of the planned transaction size relative to the issuer’s broader equity base disclosed in the form.

When were the GLW shares to be sold under Form 144 acquired and how?

The 9,797 common shares were acquired on 02/04/2026 through a stock option release from the issuer. The same date is listed for payment, with the nature of payment described as n/a in the disclosure table.

On which exchange and through which broker will the GLW shares be sold?

The planned sale will occur on the NYSE using UBS Financial Services Inc. as broker. The broker’s Weehawken, New Jersey address is listed, confirming the intermediary handling this Rule 144 transaction for the shareholder.

How does the GLW Form 144 sale compare with the issuer’s shares outstanding?

The filing lists 857,360,396 shares outstanding for the issuer, while the planned sale covers 9,797 shares. This context highlights that the planned Rule 144 transaction represents a very small portion of the total outstanding shares.

Does the GLW Form 144 mention any recent sales by the same shareholder?

The section requesting information on securities sold during the past three months appears without transaction details. This suggests no additional recent sales are disclosed in that part of the Form 144 excerpt provided.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/04/2026 - 12:51 PM EST Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001824647
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Corning Incorporated
SEC File Number	001-03247
Address of Issuer	One Riverfront Plaza Corning NEW YORK 14831
Phone	607-974-7430
Name of Person for Whose Account the Securities are To Be Sold	Fang Li
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
common	UBS Financial Services Inc 1000 Harbor Blvd 3rd Floor Weehawken NJ 07086	9797	1112051.43	857360396	02/04/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
common	02/04/2026	stock option release	issuer			9797	02/04/2026	n/a

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks
Date of Notice	02/04/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/Mijo Suric, for UBS Financial Services Inc, as attorney-in-fact for Fang Li
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)